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a  b  s  t  r  a  c  t
INTRODUCTION:  Herein,  we  present  a case  of an elderly  gentleman  who  presented  with  an  extensive
intramural  hematoma  of  the aorta  which  was  treated  with  a percutaneous  placement  of an  endovascular
stent.
PRESENTATION  OF  CASE:  A 79-year-old  male  with a history  of  hypertension  presented  to  the  emergency
department  because  of  sudden  onset  of  substernal  chest  pain  radiating  to  his  back.  A  chest computerized
tomography  scan  was  performed  that  demonstrated  a Type  A aortic  wall  intramural  hematoma  involving
the  arch  and  ascending  aorta  dissecting  both  antegrade  and  retrograde  from  a penetrating  ulcer  located
in  the  descending  aorta,  immediately  distal  to the left subclavian  artery.  No  dissection  ﬂap  was  noted.
The  patient  opted  for  an  endovascular  approach.  He was  treated  with  the  placement  of a  stent  just  distal
to  the  left  subclavian  artery,  with  good  results  noted  on follow-up  exam  performed  3  months  later.
DISCUSSION: The  treatment  of a  Type  A  IMH  lacks  consensus,  but  the majority  do favor  surgical  manage-
ment.  The  data  are  limited;  however,  there  are reports  of  patients  with  Type  A intramural  hematoma
treated  with  descending  aortic  endograft  at the  site  of  the  culprit  ulcerated  plaque,  with satisfactory
results.
CONCLUSION:  In a select  group  of  patients,  an  endovascular  approach  for the  treatment  of a  Type A  aortic
a  cau
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. Introduction
A 79-year-old male retired physician, with history of hyper-
ensive cardiovascular disease presented to the emergency
epartment after the sudden onset of substernal chest pain radi-
ting to his back. Upon evaluation, the patient was noted to
ave signiﬁcant hypertension without electrocardiogram or car-
iac enzyme abnormalities. A chest computerized tomography scan
as performed that demonstrated a Type A aortic wall IMH  involv-
ng the arch and ascending aorta dissecting both antegrade and
etrograde from a penetrating ulcer located in the descending aorta,
Open access under CC BY-NC-Nmmediately distal to the left subclavian artery (Fig. 1). No dissec-
ion ﬂap was identiﬁed.
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The patient was admitted to the intensive care unit for blood
pressure control and a transesophageal echocardiogram was  per-
formed, conﬁrming the presence of the aortic IMH  without distinct
dissection ﬂap, lack of involvement of the coronary arteries or
cardiac sinuses, and the absence of a pericardial effusion. It was
felt that the inciting event was a Type B penetrating ulcer in the
proximal descending aorta which had dissected the aortic media
antegrade and retrograde to form a Type A IMH. All treatment
options were given to the patient, and he opted for an endovascular
approach to possibly prevent further progression of the IMH.
The  patient was  taken to the cardiac catheterization laboratory
where an aortic angiography was  performed and a 24-F sheath was
used to deploy a 40 mm × 40 mm × 15 cm thoracic endoprosthesis
(GORE Medical, Newark, DE) just distal to the left subclavian artery
extending to the mid  descending thoracic aorta. Angiography was
subsequently performed to ensure placement of the endograft. The
patient tolerated the procedure without complication and was dis-
charged on post procedure day four. Follow-up at 3 days revealed
se.no further symptoms or complications. Interval imaging computer-
ized tomography performed at 3 months demonstrated complete
resolution of the IMH  without evidence of penetrating ulceration,
endoleak, or malignant progression (Fig. 2).
s Ltd. Open access under CC BY-NC-ND license.
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tematoma  extending antegrade to the ascending aorta (long arrow) and retrograde
o  the descending thoracic aorta (short arrow) from the distal arch ulceration.
. Discussion
Intramural hematomas are thought to originate from the spon-
aneous rupture of the vasa-vasorum into the intima media of the
ortic wall which can dissect both in an antegrade and retrograde
irection.1 This creates an inherent weakness in the aortic wall that
ften results in a malignant progression to aneurysm formation,
issection, or rupture.2 The working deﬁnition of an IMH  is com-
only referred to as an aortic dissection without an identiﬁable
ig. 2. At 3 months follow-up, contrast enhanced axial CT images demonstrating
ndovascular  stent placement in the descending thoracic aorta (short arrow) with
nterval resolution of intramural hematoma, including the antegrade component in
he ascending aorta (long arrow).PEN  ACCESS
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intimal ﬂap or ﬂow within a false lumen. Additionally, IMH  has been
classiﬁed using Stanford nomenclature for aortic dissection, with
Type A indicating involvement of the ascending aorta, and Type B
indicating involvement isolated to the descending aorta. This has
led many to classify IMH  within a spectrum of aortic dissection,
or as a “thrombosed dissection”.3 Others, however, call for IMH  to
be recognized as a separate entity exclusive of both dissection and
what is referred to as a potential subtype of IMH, a penetrating
ulcer.4
The treatment of a Type A IMH  lacks consensus, but the majority
advocate for surgical management, while a minority favors med-
ical therapy.5 There is a tendency of Type A IMH  to progress to
aortic dissection, rupture, or aneurysm formation and an increased
mortality when compared with medical management alone.6,7
Few studies have shown interval resolution of IMH without
progression to aneurysm, dissection, or rupture.2 The current lit-
erature supports surgical management of Type A IMH, and there is
a paucity of data addressing endovascular management as a treat-
ment option. Endovascular treatment of a penetrating ulcer in the
descending aorta is not unique.8 Monnin-Bares et al. reviewed 15
patients with IMH  in which 3 of the patients had Type A treated
with descending aortic endograft at the site of the culprit ulcerated
plaque.9 Similarly, Grimm et al. treated 8 patients with total aorta
hematoma with endovascular stent deployed at site of the ulcer-
ated plaque.10 The decision to perform endovascular stent-graft
placement in these studies, as in our case, was predicated by the
identiﬁcation of a penetrating ulceration, and both reports resulted
in a benign post-intervention course with follow up resolution of
the IMH.
However, previous literature discussing endovascular man-
agement of Type B dissection and penetrating ulceration of the
descending aorta fails to address treatment in the setting of Type
A IMH. It has been shown that IMH  is often associated with intimal
plaque ulceration and the combination of the two entities can lead
to progression of the disease process.11–13
Given the consensus recommendations for endovascular man-
agement of penetrating aortic ulcers, and their association with
IMH, endovascular stent-graft placement may be a viable treat-
ment option for Type A IMH  when an ulcerated focal defect can be
identiﬁed. Our case report demonstrates that in a select group of
patients endovascular treatment for Type A IMH  caused by an ulcer-
ated plaque may  be more conservative and possibly a deﬁnitive
treatment option.
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